PAVmed (PAVM) Competitors $0.75 -0.02 (-2.34%) Closing price 03/28/2025 04:00 PM EasternExtended Trading$0.74 -0.01 (-1.87%) As of 03/28/2025 05:27 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock PAVM vs. NMTC, MDAI, NXL, OM, COCH, PYPD, NAOV, DRIO, SURG, and PTHLShould you be buying PAVmed stock or one of its competitors? The main competitors of PAVmed include NeuroOne Medical Technologies (NMTC), Spectral AI (MDAI), Nexalin Technology (NXL), Outset Medical (OM), Envoy Medical (COCH), PolyPid (PYPD), NanoVibronix (NAOV), DarioHealth (DRIO), SurgePays (SURG), and Pheton Holdings Ltd Class A Ordinary Shares (PTHL). These companies are all part of the "medical equipment" industry. PAVmed vs. NeuroOne Medical Technologies Spectral AI Nexalin Technology Outset Medical Envoy Medical PolyPid NanoVibronix DarioHealth SurgePays Pheton Holdings Ltd Class A Ordinary Shares NeuroOne Medical Technologies (NASDAQ:NMTC) and PAVmed (NASDAQ:PAVM) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, earnings, institutional ownership, media sentiment, valuation, risk, community ranking, analyst recommendations and dividends. Which has higher earnings and valuation, NMTC or PAVM? NeuroOne Medical Technologies has higher revenue and earnings than PAVmed. NeuroOne Medical Technologies is trading at a lower price-to-earnings ratio than PAVmed, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNeuroOne Medical Technologies$5.75M4.62-$12.32M-$0.26-3.31PAVmed$3.00M2.77-$64.18M-$2.25-0.33 Do analysts rate NMTC or PAVM? PAVmed has a consensus target price of $19.00, suggesting a potential upside of 2,433.33%. Given PAVmed's stronger consensus rating and higher possible upside, analysts clearly believe PAVmed is more favorable than NeuroOne Medical Technologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score NeuroOne Medical Technologies 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00PAVmed 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 3.50 Is NMTC or PAVM more profitable? PAVmed has a net margin of 602.97% compared to NeuroOne Medical Technologies' net margin of -82.17%. PAVmed's return on equity of 0.00% beat NeuroOne Medical Technologies' return on equity.Company Net Margins Return on Equity Return on Assets NeuroOne Medical Technologies-82.17% -270.70% -129.70% PAVmed 602.97%N/A -92.36% Do insiders and institutionals hold more shares of NMTC or PAVM? 16.1% of NeuroOne Medical Technologies shares are held by institutional investors. Comparatively, 19.9% of PAVmed shares are held by institutional investors. 8.9% of NeuroOne Medical Technologies shares are held by company insiders. Comparatively, 11.3% of PAVmed shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Does the media favor NMTC or PAVM? In the previous week, PAVmed had 10 more articles in the media than NeuroOne Medical Technologies. MarketBeat recorded 12 mentions for PAVmed and 2 mentions for NeuroOne Medical Technologies. NeuroOne Medical Technologies' average media sentiment score of 1.43 beat PAVmed's score of 0.04 indicating that NeuroOne Medical Technologies is being referred to more favorably in the media. Company Overall Sentiment NeuroOne Medical Technologies Positive PAVmed Neutral Does the MarketBeat Community prefer NMTC or PAVM? PAVmed received 140 more outperform votes than NeuroOne Medical Technologies when rated by MarketBeat users. However, 71.59% of users gave NeuroOne Medical Technologies an outperform vote while only 66.12% of users gave PAVmed an outperform vote. CompanyUnderperformOutperformNeuroOne Medical TechnologiesOutperform Votes6371.59% Underperform Votes2528.41% PAVmedOutperform Votes20366.12% Underperform Votes10433.88% Which has more volatility & risk, NMTC or PAVM? NeuroOne Medical Technologies has a beta of 0.48, suggesting that its share price is 52% less volatile than the S&P 500. Comparatively, PAVmed has a beta of 1.19, suggesting that its share price is 19% more volatile than the S&P 500. SummaryPAVmed beats NeuroOne Medical Technologies on 13 of the 19 factors compared between the two stocks. Remove Ads Get PAVmed News Delivered to You Automatically Sign up to receive the latest news and ratings for PAVM and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PAVM vs. The Competition Export to ExcelMetricPAVmedSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$8.50M$4.35B$5.64B$7.84BDividend YieldN/A32.64%4.59%4.01%P/E Ratio-0.1728.4223.4118.71Price / Sales2.7749.28387.8590.69Price / CashN/A51.0838.1734.64Price / Book-0.226.126.894.23Net Income-$64.18M$67.64M$3.20B$247.26M7 Day Performance-7.41%-5.19%-3.01%-2.21%1 Month Performance1.35%-4.06%1.55%-5.74%1 Year Performance-64.95%10.68%9.37%-0.80% PAVmed Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PAVMPAVmed4.4424 of 5 stars$0.75-2.3%$19.00+2,433.3%-65.0%$8.50M$3.00M-0.1790Short Interest ↓News CoverageNMTCNeuroOne Medical Technologies0.8304 of 5 stars$1.08flatN/A-28.3%$33.33M$5.75M-4.1520Short Interest ↓MDAISpectral AI3.0187 of 5 stars$1.76+13.5%$4.75+169.9%-46.9%$32.72M$27.26M-2.7183Earnings ReportShort Interest ↓News CoverageGap UpNXLNexalin Technology3.2539 of 5 stars$2.37+10.2%$3.00+26.6%+36.4%$31.53M$162,078.00-3.703Short Interest ↓Positive NewsGap UpOMOutset Medical1.9703 of 5 stars$0.58+4.5%$4.50+678.4%-62.2%$31.16M$113.69M-0.23520Stock SplitShort Interest ↓Gap UpCOCHEnvoy Medical2.5744 of 5 stars$1.53+7.0%$8.00+422.9%-65.3%$30.98M$278,000.000.0034Positive NewsPYPDPolyPid2.7439 of 5 stars$3.03+1.5%$11.33+274.7%-45.2%$30.83MN/A-0.6180Short Interest ↓Gap DownNAOVNanoVibronix0.7196 of 5 stars$3.43+55.2%N/A-61.8%$29.90M$3.29M-2.7920Short Interest ↓Gap UpHigh Trading VolumeDRIODarioHealth2.7921 of 5 stars$0.69+3.0%$1.50+118.7%-59.3%$27.68M$27.04M-0.73200SURGSurgePays3.1978 of 5 stars$1.21+2.5%$8.50+602.5%-53.5%$24.40M$83.60M-1.0740Earnings ReportOptions VolumeAnalyst RevisionNews CoverageGap DownPTHLPheton Holdings Ltd Class A Ordinary SharesN/A$3.67-12.2%N/AN/A$24.16M$572,291.000.0011Positive NewsGap Up Remove Ads Related Companies and Tools Related Companies NeuroOne Medical Technologies Competitors Spectral AI Competitors Nexalin Technology Competitors Outset Medical Competitors Envoy Medical Competitors PolyPid Competitors NanoVibronix Competitors DarioHealth Competitors SurgePays Competitors Pheton Holdings Ltd Class A Ordinary Shares Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PAVM) was last updated on 3/29/2025 by MarketBeat.com Staff From Our PartnersA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PAVmed Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share PAVmed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy PAVM Stock Free PAVM Stock Alerts